Cite
HARVARD Citation
Merriam, J. et al. (2021). What are the risks and benefits of discontinuing oxytocin after reaching the active phase of labor in patients undergoing labor induction or augmentation?. Evidence-based practice. 24 (10), pp. 23-24. [Online].